1,7-phenanthroline has been researched along with sq-23377 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burgoyne, RD; Cheek, TR; Harris, B | 1 |
| Hardy, K; Hunt, NH | 1 |
| Pliyev, BK | 1 |
3 other study(ies) available for 1,7-phenanthroline and sq-23377
| Article | Year |
|---|---|
Effects of metalloendoproteinase inhibitors on secretion and intracellular free calcium in bovine adrenal chromaffin cells.
Topics: Adrenal Medulla; Animals; Calcium; Catecholamines; Cattle; Chromaffin Granules; Chromaffin System; Endopeptidases; Ethers; In Vitro Techniques; Ionomycin; Metalloendopeptidases; Nicotine; Phenanthrolines; Phenylalanine; Potassium; Protease Inhibitors | 1986 |
Effects of a redox-active agent on lymphocyte activation and early gene expression patterns.
Topics: Antioxidants; Cell Proliferation; Chelating Agents; Copper; Extracellular Signal-Regulated MAP Kinases; Gene Expression Profiling; Gene Expression Regulation; Humans; Interleukin-2; Ionomycin; Lymphocyte Activation; NF-kappaB-Inducing Kinase; Phenanthrolines; Phosphorylation; Proline; Protein Serine-Threonine Kinases; T-Lymphocytes; Tetradecanoylphorbol Acetate; Thiocarbamates; Transcription Factor AP-1 | 2004 |
Activated human neutrophils rapidly release the chemotactically active D2D3 form of the urokinase-type plasminogen activator receptor (uPAR/CD87).
Topics: Animals; Cell Line; Chelating Agents; Chemotaxis; Dipeptides; Ethylenediamines; Exocytosis; Glycosylphosphatidylinositols; Humans; Hydroxamic Acids; Ionomycin; Ionophores; Metalloproteases; Neutrophils; Pentetic Acid; Phenanthrolines; Phospholipase D; Receptors, Urokinase Plasminogen Activator | 2009 |